BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $12.3 million in its second quarter.
On a per-share basis, the Boston-based company said it had a loss of 15 cents.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The biopharmaceutical company posted revenue of $23.2 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $10.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLUE at https://www.zacks.com/ap/GLUE
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
